SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs acknowledged affair with a businesswoman reportedly suspected of ties to Chinese intelligence, and Nvidias board investigation into related concerns, are weighing on shares. Traders disagree on whether the episode threatens leadership and investor confidence or is an overreaction with little impact on Nvidias AI-chip business; dip-buying and bearish calls are both prominent.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs stronger-than-expected Q3 results and raised full-year revenue outlook are driving attention, with traders also pointing to record backlog and demand for its quantum systems. Bulls welcome the growth and commercial momentum, while skeptics question cash burn, acquisition-driven revenue, and dilution.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims Q3 earnings are in focus after a sharp selloff, with traders weighing the impact of its Eli Lilly deal to offer branded obesity drugs on the platform. Bulls see expanded GLP-1 access as a growth opportunity, while skeptics worry the shift from compounded products could pressure margins; claims of leaked results remain speculation.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels positive Phase 3 prostate cancer results and planned CAN-2409 BLA filing are the main focus, with recent SITC immune-profiling and viral-shedding data drawing added attention to the program. Bulls see the data and filing as potential catalysts, while skeptics question the timeline, financing needs and managements transparency.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk shares are surging ahead of its Q3 earnings report, with traders attributing the move to short covering and speculating about a possible earnings leak, though no leak is confirmed. The rally is contentious: some expect a turnaround or squeeze, while others fear the report and outlook will disappoint after weakening growth.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two is drawing attention ahead of its earnings report and the scheduled GTA VI launch, with traders focused on preorder demand, managements outlook and the games potential for ongoing online revenue. Many expect the blockbuster to drive growth, while others argue its success is already priced in and the shares may need concrete sales results to move higher.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys engine, technology-licensing and engineering agreement with AST SpaceMobile for its planned Blacklift rocket, alongside NASAs CLPS 2 selection, is driving attention. Traders see the deal as validation and a boost to Fireflys backlog, while debating execution, the stock component of the agreement and funding risks ahead of earnings.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

CAPR is drawing attention ahead of the FDAs decision on deramiocel for Duchenne muscular dystrophy, with traders focused on whether the amended applications HOPE-3 upper-limb data will support approval; the trial investigators support letter is a bullish talking point, while the earlier advisory-panel vote concerned the cardiac indication. Sentiment is largely optimistic, with calls and short-squeeze potential frequently discussed, but traders also acknowledge the binary risk of a rejection or another delay.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs sharp rebound is being linked to Oppenheimers upgrade and Google Clouds use of AMD EPYC processors in its AI infrastructure, while traders also see Nvidias CEO investigation as a reason for money to rotate toward AMD. Bulls view the companys data-center momentum and rival-related headlines as supportive, while skeptics warn the move may be a volatile bounce after the recent semiconductor selloff.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys QNX and Valeo collaboration on a production-ready smart-camera platform, with design wins at multiple Chinese automakers, is driving attention. Many traders view it as evidence of expanding QNX adoption in automotive and a growth catalyst, while skeptics question how quickly wins will translate into meaningful revenue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Colgate-Palmolive vs. Kraft Heinz: With the Market Turmoil, Which Stock Is a Better Buy?

Key PointsColgate-Palmolive maintains a dominant global presence in oral care and continues to drive consistent cash flow from its household and pet nutrition segments...

Here's Why Dividend Kings Coca-Cola, Procter & Gamble, and Colgate-Palmolive Are Hitting 52-Week Highs Following Midterm Election Results

Key PointsCoca-Cola, Procter & Gamble, and Colgate-Palmolive are attracting investors seeking reliable earnings and dividends amid political uncertainty...

Can PG's Premium Brands Hold Up in a Value-Seeking Market?

P&G's premium brands benefit from innovation and strong loyalty, but rising costs and value-conscious consumers pose challenges to sustaining growth.

Colgate-Palmolive vs. Lululemon Athletica: Which Consumer Goods Stock Is a Better Buy in 2026?

Key PointsColgate-Palmolive generates significant free cash flow from its dominant position in global household essentials...

Colgate Q3 Earnings Beat Estimates on Organic Sales & Pricing Gains

CL's Q3 earnings and sales beat estimates, fueled by organic growth, pricing gains and productivity efforts, prompting a higher 2026 profitability outlook.

Colgate-Palmolive Beats Q3 Estimates, Raises Profit Outlook Despite Weak US Demand, Rising Costs

Colgate-Palmolive beats Q3 2026 earnings and revenue estimates, raises profit and margin outlook, but faces weak US demand and rising costs.read more...

Clorox's Q1 Earnings Coming Up: Key Insights for Investors

CLX's fiscal first-quarter 2027 results are likely to benefit from innovation, brand investments and GOJO, while cost pressures and cautious spending may have posed challenges. 

Colgate-Palmolive (CL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for Colgate-Palmolive (CL) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Colgate-Palmolive Co. Reveals Advance In Q3 Income

(RTTNews) - Colgate-Palmolive Co. (CL) revealed earnings for its third quarter that Increases, from the same period last year...

Colgate-Palmolive (CL) Surpasses Q3 Earnings and Revenue Estimates

Colgate-Palmolive (CL) delivered earnings and revenue surprises of +5.44% and +0.72%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

• Reported GAAP EPS of $0.97 up 6.59% YoY
• Reported revenue of $5.37B up 4.64% YoY
• For full year 2026, Colgate-Palmolive now expects net sales up 4% to 5%, GAAP and Base Business gross profit margin up, and Base Business earnings per share growth of 5% to 7%.

Colgate-Palmolive recorded North America organic sales and volume declines, a lower Q3 GAAP operating profit margin versus Q3 2025, and management cited consumer uncertainty and ongoing macroeconomic volatility.

Colgate-Palmolive delivered higher Q3 sales, organic sales and Base Business EPS, reported sequential worldwide volume-growth improvement while investing in premium science-based innovation, and retained leading toothpaste and manual toothbrush shares.

Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care, and Pet Nutrition segments. The Oral, Personal, and Home Care segment includes toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. The Pet Nutrition segment offers specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.

Colgate-Palmolive Co.

Colgate-Palmolive Explores Sale Of Softsoap, Irish Spring, Speed Stick Brands: Report

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>Colgate-Palmolive is exploring the sale of several personal care brands, including Softsoap, Irish Spring and Speed Stick, Reuters reported.</li><li>The company is working with Goldman Sachs on a potential divestiture that could fetch more than $1 billion.</li><li>The potential sales come as Colgate reshapes its portfolio and expands a productivity program expected to generate $200 million to $300 million in annualized pre-tax savings.</li></ul>Colgate-Palmolive (CL) is reportedly exploring the sale of several mass-market personal care brands, including Softsoap, Irish Spring and Speed Stick, in a potential deal that could fetch more than $1 billion.According to a Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/world/colgate-palmolive-seeks-divest-some-personal-care-brands-sources-say-2026-09-11/">report</a> citing people familiar with the matter, the company is working with Goldman Sachs (GS) on the potential divestiture.At the time of writing, CL shares traded marginally in the red.<h2 class="st-heading-2">Colgate-Palmolive's Personal Care Business</h2>Colgate's personal care portfolio includes deodorants, bar and liquid soaps, shower gels and skin care products. The company’s 2025 annual report lists Softsoap, Irish Spring, Lady Speed Stick and Speed Stick, among others, within its personal care portfolio.Personal Care accounted for 17% of Colgate-Palmolive's worldwide net sales in 2025, down from 18% in 2024 and 19% in 2023. Colgate reported total 2025 net sales of $20.38 billion, putting the personal care category at roughly $3.5 billion in annual sales.The company does not separately disclose revenue for individual brands such as Softsoap, Irish Spring or Speed Stick.Colgate's largest product category is oral care, which represented 44% of 2025 net sales, while home care accounted for 16% and pet nutrition for 23%.<h2 class="st-heading-2">Colgate Looks To Reshape Its Brand Portfolio</h2>The potential divestiture comes as Colgate is already carrying out a broader productivity and restructuring program.In April, Colgate-Palmolive’s board expanded its Strategic Growth and Productivity Program, increasing the estimated cumulative pre-tax charges to $350 million to $550 million, from the previous $200 million to $300 million range.&nbsp;Colgate expects substantially all of the charges to be incurred by the end of 2028 and expects the expanded program to generate annual pre-tax savings of $200 million to $300 million once all initiatives are approved and implemented.The program includes efforts to optimize the global supply chain and align the company's organizational structure with its strategy, with investments in innovation, data, analytics, artificial intelligence, and omnichannel demand generation.The potential brand sales come as Colgate works to improve its North American business. In its second-quarter 2026 results, Colgate reported net sales growth of 4.9% and organic sales growth of 2.4%, while North American net sales and organic sales each declined 3% year over year, according to the company’s earnings release.Colgate CEO Noel Wallace said at the Barclays consumer conference this week that competition in North America was intensifying and that getting the business where it needs to be would require a “long-term turnaround,” Reuters reported.<h2 class="st-heading-2">Broader Consumer-Goods Divestiture Trend</h2>Colgate's potential move comes amid a broader reshaping of large consumer-goods companies.Unilever has been restructuring its portfolio, including the planned combination of its food business with McCormick in March, while Nestle recently agreed to sell its mainstream vitamins business to Yellow Wood Partners for around $1 billion.Unilever has also previously sold more than 20 beauty and personal care brands to Yellow Wood Partners, while its Magnum ice cream business was separated from the company.Colgate's potential transaction would involve only some brands within its personal care business, rather than a sale of the entire division, according to the Reuters report.On Stocktwits, retail sentiment for&nbsp;<a href="https://stocktwits.com/symbol/CL">CL&nbsp;</a>was ‘bullish’ early Friday. CL shares have gained over 9% year-to-date.Read more:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/kr-stock-declines-after-company-cuts-identical-sales-forecast-for-2026-a-look-at-some-key-highlights/cZtXjyKRBGv">KR Stock Declines After Company Cuts Identical Sales Forecast For 2026 – A Look At Some Key Highlights</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a person holds a smartphone displaying the logo of Colgate-Palmolive Company (NYSE: CL), an American consumer products company focused on the production, distribution, and provision of household, health care, and personal care products, with the company's blue CP logo visible in the background, on July 29, 2025 in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

According to a Reuters report, Colgate is planning to divest certain personal care brands, with the sale expected to fetch more than $1 billion.

Goldman Sachs Group, Inc.

Buying the dip

Selling or trimming

Holding

Waiting for the investigation results to decide

Nvidia ($NVDA) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Stocktwits

) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Current Price	$97.76
Prev Close	$96.56
Open	$97.40
Dividend Yield	2.61%
50-Day Moving Average	$90.14
Beta	0.02
Avg. Volume	4.94M
PE Ratio	37.72

52-Week High	$101.18
52-Week Low	$75.96
Market Capitalization	$76.76B
EPS (Annual)	$2.63
Price to Book	266.52
Revenue Per Employee	$606,607.14

Feed

News

Sentiment

Earnings

Fundamentals

Info

CL Fundamentals